Biopharma Daily Stock Updates - 08/06/21Aug 6, 20211 min read$XBI $127.29 -2% Pipeline Updates$SPPI -21.5% Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim). source$ETON -10% PDUFA date for topiramate extended to November, 6, 2021. source $XENT +12% Acquired by Medtronic. source Posted by DV
$XBI $127.29 -2% Pipeline Updates$SPPI -21.5% Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim). source$ETON -10% PDUFA date for topiramate extended to November, 6, 2021. source $XENT +12% Acquired by Medtronic. source Posted by DV
Comments